Self-Gated CINE MRI for Combined Contrast-Enhanced Imaging and Wall-Stiffness Measurements of Murine Aortic Atherosclerotic Lesions

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  den Adel, Brigit ^a   van der Graaf, Linda M ^a   Strijkers, Gustav J ^b   Lamb, Hildo J ^a   Poelmann, Robert E ^a   van der Weerd, Louise ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ATORVASTATIN; GADOLINIUM PENTETATE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICELLE;

AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; ARTIFACT REDUCTION; ASCENDING AORTA; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; JUVENILE ANIMAL; MALE; MICELLE; MOUSE; NONHUMAN; RETROSPECTIVE GATED CINE MAGNETIC RESONANCE IMAGING; ANIMAL; AORTA; ARTIFACT; ATHEROSCLEROSIS; C57BL MOUSE; GENETICS; METABOLISM; MOTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; AORTA; APOLIPOPROTEINS E; ARTIFACTS; ATHEROSCLEROSIS; CONTRAST MEDIA; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICELLES; MOTION; PLAQUE, ATHEROSCLEROTIC;

EID: 84874603835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057299     Document Type: Article

References (40)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S,et al. (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215. CIRCULATIONAHA.109.192667 [pii];10.1161/CIRCULATIONAHA.109.192667 [doi].
2. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30: 1282-1292. 30/7/1282 [pii];10.1161/ATVBAHA.108.179739 [doi].
3. Virmani R, Burke AP, Kolodgie FD, Farb A, (2002) Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15: 439-446.
4. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, et al. (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236-1241.
5. John S, Schneider MP, Delles C, Jacobi J, Schmieder RE (2005) Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 149: 473. S0002870304006088 [pii];10.1016/j.ahj.2004.06.027 [doi].
6. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG,et al. (2007) Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A 104: 961-966. 0606281104 [pii];10.1073/pnas.0606281104 [doi].
7. Burtea C, Laurent S, Mahieu I, Larbanoix L, Roch A,et al. (2011) In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media Mol Imaging 6: 236-250. 10.1002/cmmi.423 [doi].
8. Yamakoshi Y, Qiao H, Lowell AN, Woods M, Paulose B,et al. (2011) LDL-based nanoparticles for contrast enhanced MRI of atheroplaques in mouse models. Chem Commun (Camb) 47: 8835-8837. 10.1039/c1cc10924c [doi].
9. Klug G, Kampf T, Ziener C, Parczyk M, Bauer E,et al. (2009) Murine atherosclerotic plaque imaging with the USPIO Ferumoxtran-10. Front Biosci 14: 2546-2552. 3396 [pii].
10. Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC,et al. (2008) p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol 28: 265-271. ATVBAHA.107.151175 [pii];10.1161/ATVBAHA.107.151175 [doi].
11. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, et al. (2002) Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 106: 1368-1373.
12. Li ZY, Howarth S, Trivedi RA, King-Im JM, Graves MJ,et al. (2006) Stress analysis of carotid plaque rupture based on in vivo high resolution MRI. J Biomech 39: 2611-2622. S0021-9290(05)00399-4 [pii];10.1016/j.jbiomech.2005.08.022 [doi].
13. Lehmann ED, Hopkins KD, Jones RL, Rudd AG, Gosling RG, (1995) Aortic distensibility in patients with cerebrovascular disease. Clin Sci (Lond) 89: 247-253.
14. Yu HY, Peng HH, Wang JL, Wen CY, Tseng WY (2006) Quantification of the pulse wave velocity of the descending aorta using axial velocity profiles from phase-contrast magnetic resonance imaging. Magn Reson Med 56: 876-883. 10.1002/mrm.21034 [doi].
15. Herold V, Wellen J, Ziener CH, Weber T, Hiller KH,et al. (2009) In vivo comparison of atherosclerotic plaque progression with vessel wall strain and blood flow velocity in apoE(-/-) mice with MR microscopy at 17.6 T. MAGMA 22: 159-166. 10.1007/s10334-008-0160-0 [doi].
16. Parczyk M, Herold V, Klug G, Bauer WR, Rommel E,et al. (2010) Regional in vivo transit time measurements of aortic pulse wave velocity in mice with high-field CMR at 17.6 Tesla. J Cardiovasc Magn Reson 12: 72. 1532-429X-12-72 [pii];10.1186/1532-429X-12-72 [doi].
17. Nahrendorf M, Wiesmann F, Hiller KH, Han H, Hu K, et al. (2000) In vivo assessment of cardiac remodeling after myocardial infarction in rats by cine-magnetic resonance imaging. J Cardiovasc Magn Reson 2: 171-180.
18. Heijman E, de Graaf W, Niessen P, Nauerth A, van Eys G,et al. (2007) Comparison between prospective and retrospective triggering for mouse cardiac MRI. NMR Biomed 20: 439-447. 10.1002/nbm.1110 [doi].
19. Faraci FM, Sigmund CD, (1999) Vascular biology in genetically altered mice: smaller vessels, bigger insight. Circ Res 85: 1214-1225.
20. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R, (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140.
21. Plump AS, Breslow JL (1995) Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr 15: 495-518. 10.1146/annurev.nu.15.070195.002431 [doi].
22. Mulder WJ, Strijkers GJ, Vucic E, Cormode DP, Nicolay K,et al. (2007) Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis. Top Magn Reson Imaging 18: 409-417. 10.1097/rmr.0b013e31815a0e7f [doi];00002142-200710000-00011 [pii].
23. Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, et al. (2007) Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn Reson Med 58: 1164-1170. 10.1002/mrm.21315 [doi].
24. Wang YX, Halks-Miller M, Vergona R, Sullivan ME, Fitch R, et al. (2000) Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 278: H428-H434.
25. den Adel B, van der Graaf LM, Que I, Strijkers GJ, Lowik C, et al. (2013) Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal study. Contrast Media Mol Imaging 8: 63-71.
26. Mulder WJ, Strijkers GJ, Griffioen AW, van Bloois L, Molema G,et al. (2004) A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 15: 799-806. 10.1021/bc049949r [doi].
27. Rouser G, Fkeischer S, Yamamoto A, (1970) Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5: 494-496.
28. Morrison TM, Choi G, Zarins CK, Taylor CA (2009) Circumferential and longitudinal cyclic strain of the human thoracic aorta: age-related changes. J Vasc Surg 49: 1029-1036. S0741-5214(08)01990-3 [pii];10.1016/j.jvs.2008.11.056 [doi].
29. Bergwerff M, Verberne ME, Deruiter MC, Poelmann RE, Gittenberger-de Groot AC, (1998) Neural crest cell contribution to the developing circulatory system: implications for vascular morphology? Circ Res 82: 221-231.
30. den Adel B, Bovens SM, Boekhorst BT, Strijkers GJ, Poelmann RE,et al. (2012) Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: The do's and don't's. Atherosclerosis 225(2): 274-80. S0021-9150(12)00500-X [pii];10.1016/j.atherosclerosis.2012.07.028 [doi].
31. Shaaban AM, Duerinckx AJ, (2000) Wall shear stress and early atherosclerosis: a review. AJR Am J Roentgenol 174: 1657-1665.
32. Van der Heiden K, Hierck BP, Krams R, de Crom R, Cheng C,et al. (2008) Endothelial primary cilia in areas of disturbed flow are at the base of atherosclerosis. Atherosclerosis 196: 542-550. S0021-9150(07)00380-2 [pii];10.1016/j.atherosclerosis.2007.05.030 [doi].
33. te Boekhorst BC, Bovens SM, Rodrigues-Feo J, Sanders HM, van de Kolk CW,et al. (2010) Characterization and in vitro and in vivo testing of CB2-receptor- and NGAL-targeted paramagnetic micelles for molecular MRI of vulnerable atherosclerotic plaque. Mol Imaging Biol 12: 635-651. 10.1007/s11307-010-0323-z [doi].
34. Miraux S, Calmettes G, Massot P, Lefrancois W, Parzy E,et al. (2009) 4D retrospective black blood trueFISP imaging of mouse heart. Magn Reson Med 62: 1099-1105. 10.1002/mrm.22139 [doi].
35. Wiesmann F, Szimtenings M, Frydrychowicz A, Illinger R, Hunecke A,et al. (2003) High-resolution MRI with cardiac and respiratory gating allows for accurate in vivo atherosclerotic plaque visualization in the murine aortic arch. Magn Reson Med 50: 69-74. 10.1002/mrm.10500 [doi].
36. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ,et al. (2004) Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 43: 1239-1245. 10.1161/01.HYP.0000128420.01881.aa [doi];01.HYP.0000128420.01881.aa [pii].
37. Asmar RG, Topouchian JA, Benetos A, Sayegh FA, Mourad JJ,et al. (1997) Non-invasive evaluation of arterial abnormalities in hypertensive patients. J Hypertens Suppl 15: S99-107.
38. Hartley CJ, Taffet GE, Michael LH, Pham TT, Entman ML, (1997) Noninvasive determination of pulse-wave velocity in mice. Am J Physiol 273: H494-H500.
39. Metafratzi ZM, Efremidis SC, Skopelitou AS, De RA, (2002) The clinical significance of aortic compliance and its assessment with magnetic resonance imaging. J Cardiovasc Magn Reson 4: 481-491.
40. Rensen SS, Niessen PM, van Deursen JM, Janssen BJ, Heijman E,et al. (2008) Smoothelin-B deficiency results in reduced arterial contractility, hypertension, and cardiac hypertrophy in mice. Circulation 118: 828-836. CIRCULATIONAHA.107.743690 [pii];10.1161/CIRCULATIONAHA.107.743690 [doi].